https://www.selleckchem.com/HDAC.html
Overall five-year survival was 47.3%. The median overall survival (OS) was 63months (range 1-222), and the median disease-free survival (DFS) was 50months (0-122). The median follow-up time for non-censored patients was 84months (range 60-122). We found significant survival differences between the newly defined stages 1A1, 1A2 and 1A3 (previously 1A). We also found that the 8th edition of TMN classification was a significantly better predictor of long-term survival, compared to the 7th edition. We found significant survival differences between the
כמו
תגובה
לַחֲלוֹק
